– USA, NJ – Ortho Clinical Diagnostics today announced the appointments of accomplished industry veterans Carl Hull, Ron Labrum, Thomas Mac Mahon and José (Joe) E. Almeida as independent members of the Board of Directors of the Company’s parent, Ortho-Clinical Bermuda Co. Ltd. OCD became a stand-alone company in July 2014. These appointments bring the total number of directors to ten.
“We are pleased to welcome Carl, Ron, Tom and Joe, who each brings the wealth of related industry experience needed to help us revitalize Ortho Clinical Diagnostics as a premier in vitro diagnostics company,” said Martin D. Madaus, Chairman and Chief Executive Officer of Ortho Clinical Diagnostics. “Their deep expertise across clinical laboratories and transfusion medicine will provide valuable insights as we look to transform our company and enhance our focus on our customers.”
Carl Hull is the former Chairman and Chief Executive Officer of Gen-Probe, a molecular diagnostics company. He is a 30-plus year veteran of the diagnostics and life sciences industries. Previously, Mr. Hull held executive positions at Applied Biosystems, Applied Imaging, Ventana Medical Systems and Abbott Diagnostics. He served as the Chairman of the Board of the California Healthcare Institute from 2010 to 2012 and previously served on the Board of Directors of AdvaMedDx, an industry advocacy organization.
Ron Labrum most recently served as President and Chief Executive Officer of Fenwal, a global leader in transfusion technology. His prior role was as Chairman and Chief Executive Officer of Cardinal Health’s Healthcare Supply Chain Services segment. Mr. Labrum has more than 30 years of experience in the medical device and distribution industry, serving in senior leadership roles with Fortune 100 companies including Allegiance Corporation, Baxter International and American Hospital Supply Corporation. He currently serves as Chairman of the Board of Suture Express and he is a director of Wright Medical Group and Great Basin Scientific.
Thomas Mac Mahon currently serves as an Executive Partner at Foundation Medical Partners, a healthcare-focused venture capital fund. He is the former Chairman and Chief Executive Officer of Laboratory Corporation of America, one of the largest U.S. medical testing companies. Mr. Mac Mahon began his career with Roche Laboratories, eventually becoming responsible for all U.S. diagnostic operations of Roche. He currently serves as the lead outside director for Express Scripts, Inc., and is also a director of SynapDx Corporation and PharMerica Corporation, among others.
José (Joe) E. Almeida is Chairman, President and Chief Executive Officer of Covidien plc. He has served as chairman of Covidien’s Board of Directors since March 2012 and as President, Chief Executive Officer and a Director of Covidien since 2011. Prior to being appointed to his current position, Mr. Almeida was President of the Medical Devices organization at Covidien, where he oversaw several businesses. Mr. Almeida has held leadership positions at Covidien, Greatbatch Technologies, Inc., American Home Products’ Acufex Microsurgical division and Johnson & Johnson’s Professional Products division, and began his career as a Management Consultant at Andersen Consulting (Accenture). He currently serves as Chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors and is on the Board of Directors of State Street Corporation and Partners in Health.
About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics delivers high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
